Emma V. Rivas-Vazquez, MS

  • 3Articles
  • 18.6KReads
  • 2023–2025Active
  • 8Collaborators
  • 2Citations

About

Emma V. Rivas-Vazquez, MS, is affiliated with First Choice Neurology in Miami, Florida. Since 2023, Rivas-Vazquez has published research focused on cognition, geriatric depression, and the neuropsychiatric aspects of COVID-19. Topics include screening for irritability in geriatric depression, the use of antidepressants for Long COVID, and cognitive assessment tools for early cognitive decline in diverse populations. Frequent collaborators include Rafael A. Rivas-Vazquez, Alan Quintana, Carla Rodriguez, Enrique J. Carrazana, and Gustavo J. Rey.

Publications

PCC
Irritability and Geriatric Depression
Original Research

Irritability and Geriatric Depression

January 30, 2025

The objective of this study was to determine the frequency of irritability in a sample of geriatric individuals and its clinical relevance in the detection of depression.
, , , et al
PCC
Potential Use of Antidepressants for Long COVID
Letter to the Editor

Potential Use of Antidepressants for Long COVID

May 16, 2024

The possibility of repurposing antidepressants as a potential treatment for long COVID first emerged following observations that antidepressants might reduce morbidity and mortality when administered during acute COVID.
, , , et al
PCC
Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients
Brief Report

Brief Cognitive Screener Detects Early Signs of Cognitive Decline in Anglo and Hispanic Patients

December 12, 2023

The South Florida Cognitive Screener is an 8-item self-report instrument developed to capture the most common cognitive, functional, and behavioral complaints typically reported early in the process of cognitive...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe